Home › Compare › HMRRF vs JNJ

HMRRF vs JNJ: Dividend Comparison 2026

HMRRF yields 5000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HMRRF wins by $62217131802825.34M in total portfolio value
10 years
HMRRF
HMRRF
● Live price
5000.00%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$62217131802825.35M
Annual income
$59,861,980,287,378,210,000.00
Full HMRRF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — HMRRF vs JNJ

📍 HMRRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHMRRFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HMRRF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
HMRRF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HMRRF
Annual income on $10K today (after 15% tax)
$425,000.00/yr
After 10yr DRIP, annual income (after tax)
$50,882,683,244,271,480,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, HMRRF beats the other by $50,882,683,244,271,480,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HMRRF + JNJ for your $10,000?

HMRRF: 50%JNJ: 50%
100% JNJ50/50100% HMRRF
Portfolio after 10yr
$31108565901412.68M
Annual income
$29,930,990,143,689,105,000.00/yr
Blended yield
96.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

HMRRF
No analyst data
Altman Z
45.5
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HMRRF buys
0
JNJ buys
0
No recent congressional trades found for HMRRF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHMRRFJNJ
Forward yield5000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$62217131802825.35M ✓$20.0K
Annual income after 10y$59,861,980,287,378,210,000.00 ✓$827.78
Total dividends collected$62057786341622.61M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HMRRF vs JNJ ($10,000, DRIP)

YearHMRRF PortfolioHMRRF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$510,700$500,000.00$10,676$355.77+$500.0K → HMRRF
2$24,410,935$23,864,485.98$11,407$389.39+$24.40M → HMRRF
3$1,092,192,501$1,066,072,800.30$12,198$426.53+$1092.18M → HMRRF
4$45,746,366,951$44,577,720,975.17$13,056$467.62+$45746.35M → HMRRF
5$1,793,932,828,410$1,744,984,215,772.56$13,987$513.12+$1793932.81M → HMRRF
6$65,871,973,805,320$63,952,465,678,921.49$14,998$563.56+$65871973.79M → HMRRF
7$2,265,146,887,602,700$2,194,663,875,631,007.20$16,098$619.52+$2265146887.59M → HMRRF
8$72,954,689,148,998,180$70,530,981,979,263,280.00$17,295$681.69+$72954689148.98M → HMRRF
9$2,201,076,182,660,884,700$2,123,014,665,271,456,500.00$18,599$750.82+$2201076182660.87M → HMRRF
10$62,217,131,802,825,350,000$59,861,980,287,378,210,000.00$20,022$827.78+$62217131802825.34M → HMRRF

HMRRF vs JNJ: Complete Analysis 2026

HMRRF — Stock

Hammer Metals Limited engages in the exploration and extraction of mineral resources in Australia. It primarily explores for iron oxide, copper, cobalt, and gold deposits, as well as for molybdenum and rhenium ores. The company holds 100% interests in the Mount Isa project that comprise Kalman, Overlander North and Overlander South, and Elaine deposits covering an area of approximately 2,600 square kilometers within the Mount Isa mining district, as well as a 51% interest in the Jubilee deposit. It also holds a 100% interest in the Bronzewing South gold project located in the Yandal Belt of Western Australia. The company was formerly known as Midas Resources Limited and changed its name to Hammer Metals Limited in April 2014. Hammer Metals Limited was incorporated in 2000 and is based in West Perth, Australia.

Full HMRRF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this HMRRF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HMRRF vs SCHDHMRRF vs JEPIHMRRF vs OHMRRF vs KOHMRRF vs MAINHMRRF vs ABBVHMRRF vs MRKHMRRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.